Drug Shortage Report for GD-GABAPENTIN
Report ID | 33910 |
Drug Identification Number | 02285843 |
Brand name | GD-GABAPENTIN |
Common or Proper name | GD-GABAPENTIN |
Company Name | GENMED A DIVISION OF PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | GABAPENTIN |
Strength(s) | 600MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100's |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-01-02 |
Estimated end date | |
Actual end date | 2018-02-05 |
Shortage status | Resolved |
Updated date | 2018-02-07 |
Company comments | Please note that only 1 lot with an expiry date of 6/30/2018 remains available. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2018-02-07 | French | Compare |
v6 | 2018-02-07 | English | Compare |
v5 | 2018-01-19 | French | Compare |
v4 | 2018-01-19 | English | Compare |
v3 | 2018-01-05 | English | Compare |
v2 | 2017-12-20 | French | Compare |
v1 | 2017-12-20 | English | Compare |
Showing 1 to 7 of 7